Amsterdam And Irvine
AMSTERDAM and IRVINE, California, June 20, 2011 -
- Not for release, distribution or
publication in whole or in part, directly or indirectly, into or in
the United States, Australia, Canada, OR Japan
Agendia (or the "Company"), a commercial-stage molecular cancer
diagnostics company, announces the postponement of its Initial
Public Offering ("IPO") that was due to price today.
AMSTERDAM and IRVINE, California, May 10, 2011 - Agendia, an innovative molecular cancer diagnostics company,
today announced that it has partnered with AstraZeneca and The Netherlands
Cancer Institute (NKI) to accelerate the development of targeted therapies
for colorectal cancer patients.
AMSTERDAM and IRVINE, California, January 21 - BMEYE B.V., the innovators of combined noninvasive, beat-to-beat blood
pressure and cardiac output monitoring, and Masimo (Nasdaq: MASI), the
inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion
pulse oximetry, jointly announce today CE Mark certification and the European
launch of the BMEYE ccNexfin-the first noninvasive cardiovascular monitor
with Masimo Rainbow SET Pulse CO-Oximetry technology.
